Nippon Life Global Investors Americas Inc. trimmed its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 95.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,940 shares of the company's stock after selling 241,550 shares during the period. Nippon Life Global Investors Americas Inc.'s holdings in Procter & Gamble were worth $1,589,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of the business. BlackRock Inc. acquired a new position in shares of Procter & Gamble during the 2nd quarter valued at $27,862,105,000. Bank of America Corp DE purchased a new stake in Procter & Gamble during the 2nd quarter worth $3,850,628,000. Bank of New York Mellon Corp acquired a new stake in Procter & Gamble in the 2nd quarter valued at $2,281,505,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in Procter & Gamble in the second quarter valued at about $1,480,650,000. Finally, Corient Private Wealth LP purchased a new position in Procter & Gamble in the second quarter valued at about $335,908,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Procter & Gamble Price Performance
Shares of NYSE PG opened at $161.42 on Monday. The company has a quick ratio of 0.53, a current ratio of 0.72 and a debt-to-equity ratio of 0.40. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $167.25. The business has a 50 day moving average price of $149.99 and a two-hundred day moving average price of $148.94. The firm has a market cap of $374.14 billion, a PE ratio of 24.31, a price-to-earnings-growth ratio of 3.97 and a beta of 0.36.
Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, beating the consensus estimate of $1.89 by $0.11. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The company had revenue of $23.28 billion during the quarter, compared to analysts' expectations of $22.80 billion. During the same period in the prior year, the business posted $1.99 EPS. The business's revenue was up 4.0% on a year-over-year basis. Sell-side analysts expect that Procter & Gamble Company will post 6.99 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be paid a dividend of $1.0885 per share. This represents a $4.35 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date is Friday, October 23rd. Procter & Gamble's dividend payout ratio is 65.51%.
Analyst Ratings Changes
PG has been the subject of several analyst reports. JPMorgan Chase & Co. upped their target price on Procter & Gamble from $162.00 to $180.00 and gave the stock an "overweight" rating in a research report on Friday, October 23rd. Wells Fargo & Company boosted their target price on shares of Procter & Gamble from $164.00 to $180.00 and gave the stock an "overweight" rating in a research report on Friday, October 23rd. Morgan Stanley upped their target price on shares of Procter & Gamble from $166.00 to $185.00 and gave the company an "overweight" rating in a research note on Friday, October 23rd. Barclays raised their price target on shares of Procter & Gamble from $152.00 to $165.00 and gave the company an "equal weight" rating in a report on Monday, October 26th. Finally, Royal Bank Of Canada set a $169.00 price target on shares of Procter & Gamble in a research note on Friday, October 23rd. Fifteen equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $170.57.
View Our Latest Stock Analysis on Procter & Gamble
Insider Activity
In related news, insider Marc S. Pritchard sold 4,030 shares of the business's stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $143.79, for a total value of $579,473.70. Following the completion of the sale, the insider directly owned 187,001 shares of the company's stock, valued at $26,888,873.79. The trade was a 2.11% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Shailesh Jejurikar sold 35,000 shares of the company's stock in a transaction that occurred on Friday, October 23rd. The shares were sold at an average price of $163.09, for a total value of $5,708,150.00. Following the sale, the chief executive officer owned 55,391 shares in the company, valued at $9,033,718.19. The trade was a 38.72% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 58,647 shares of company stock worth $9,268,508 over the last ninety days. Insiders own 0.23% of the company's stock.
More Procter & Gamble News
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Analyst upgrade: Freedom Broker upgraded PG from “hold” to “buy,” providing a positive signal for the stock and reflecting greater confidence in the company’s outlook. Freedom Broker upgrades Procter & Gamble to buy from hold
- Positive Sentiment: Dividend appeal remains strong: Articles highlighted PG as a long-standing dividend leader, supporting its appeal to income-focused and defensive investors. The company’s record of dividend increases may help underpin demand for the shares, particularly when investors favor stable consumer-staples businesses. Dividend Kings article Trusted dividend stocks article
- Neutral Sentiment: Bond issuance adds balance-sheet context: PG’s euro- and dollar-denominated bond sale provides liquidity and funding flexibility, but it also draws attention to leverage, interest costs, and the company’s relatively elevated valuation. Procter & Gamble bond sale
- Neutral Sentiment: Growth story under review: Commentary on PG points to accelerating revenue growth, while also noting that higher operating costs could pressure margins and earnings. Investors are weighing improved sales momentum against cost inflation. Procter & Gamble revenue growth and costs What changed in Procter & Gamble’s story
- Negative Sentiment: Mixed rating signals and valuation risk: DZ Bank downgraded PG from “strong-buy” to “hold.” With shares trading at a premium valuation, a more cautious analyst stance could weigh on upside unless earnings growth accelerates. DZ Bank rating change
- Negative Sentiment: Advertising challenge produced only a limited win: Following PG’s challenge, the National Advertising Division supported Carpe’s $19.95 reference price but recommended changes or removal of other savings, free-shipping, comparative-performance, and “first” 100-hour protection claims. The outcome may modestly strengthen competitive advertising standards, but it does not represent a material financial catalyst for PG. National Advertising Division decision involving Carpe
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Company NYSE: PG is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.
The company's well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.